Clinical interpretation of SPINK1 and CTRC variants in pancreatitis

Pancreatology. 2020 Oct;20(7):1354-1367. doi: 10.1016/j.pan.2020.09.001. Epub 2020 Sep 7.

Abstract

Since the description of the SPINK1 gene encoding the serine protease inhibitor Kazal type 1 and the CTRC gene encoding the Chymotrypsin C as being involved in chronic pancreatitis, more than 56 SPINK1 and 87 CTRC variants have been reported. Assessing the clinical relevance of SPINK1 and CTRC variants is often complicated in the absence of functional evidence and interpretation of rare variants is not very easy in clinical practice. The aim of this study was to review the different variants identified in these two genes and to classify them according to their degree of damaging effect. This classification was based on the results of in vitro experiments, in silico analysis using different prediction tools, and on population data, in comparing the allelic frequency of each variant in patients with pancreatitis and in unaffected control individuals. This review should help geneticists and clinicians in charge of patient's care and genetic counseling to interpret the results of genetic studies.

Keywords: CTRC; Pancreatitis; Penetrance; SPINK1; Variant classification.

Publication types

  • Systematic Review

MeSH terms

  • Chymotrypsin / genetics*
  • Computer Simulation
  • Gene Frequency
  • Genetic Variation
  • Humans
  • Pancreatitis / genetics*
  • Predictive Value of Tests
  • Trypsin Inhibitor, Kazal Pancreatic / genetics*

Substances

  • SPINK1 protein, human
  • Trypsin Inhibitor, Kazal Pancreatic
  • Chymotrypsin
  • chymotrypsin C